Skip to main content
Gary Lyman, MD, Oncology, Apex, NC

Gary Herbert Lyman MD MPH, FASCO, FACP, FRCP

Oncology•Apex, NC

Hematologic Oncology

Duke University, Durham NC Department of Medicine

Join to View Full Profile

  • 329 Broad Elm LaneApex, NC 27523

  • Phone+1 919-724-0038

  • Fax+1 919-724-0038

Dr. Lyman is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Lyman's Full ProfileAlready have an account?

Summary

  • Gary Lyman, MD, is an oncology specialist located in Apex, NC, with a subspecialty in hematologic oncology. Dr. Lyman completed a post-doctoral fellowship at Harvard School of Public Health and possesses extensive education in hematology and medical oncology. Areas of expertise include venous thromboembolism, thrombocytopenia, public health, hematology, and sentinel lymph node biopsy. Dr. Lyman has been published in multiple journals, contributing research on cancer trials, patient outcomes, and artificial intelligence. Clinical trial involvement includes a study on Dalteparin prophylaxis in high-risk ambulatory cancer patients. Recognitions include being named America's Top Doctors from Castle Connolly and receiving honors from the American Society of Hematology and Clinical Oncologists, among others.

Education & Training

  • Harvard School of Public Health
    Harvard School of Public HealthPost-Doctoral Fellowship, 1981 - 1982
  • University at Buffalo
    University at BuffaloFellowship, Hematology and Medical Oncology, 1974 - 1977
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Internal Medicine, 1972 - 1974
  • Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1972

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1972 - 2027
  • WA State Medical License
    WA State Medical License 2014 - 2027
  • NY State Medical License
    NY State Medical License 1974 - 2009
  • FL State Medical License
    FL State Medical License 1977 - 2002
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Distinguished Emeritus Member American Society of Hematology, 1976-2023
  • America's Top Doctors Castle Connolly, 2005-2015
  • America's Top Doctors for Cancer Castle Connolly, 2005-2015

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Aligning Cancer Clinical Trials with Cancer Burden  
    Nicole M Kuderer, Gary H Lyman, JAMA Oncology
  • Association of Generic Imatinib Availability and Pricing with Trends in Tyrosine Kinase Inhibitor Use in Patients with Chronic Myelogenous Leukemia  
    Gary Lyman, MD, JAMA Oncology

Abstracts/Posters

  • Health Care Costs Associated with Contemporary Chronic Myelogenous Leukemia (CML) Therapy Compared to Other Hematologic Malignancies (HEM)
    Gary H. Lyman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Cancer Associated Thrombosis Is Associated with Higher Mortality across All Khorana Score Risk Levels
    Gary H. Lyman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis
    Gary H. Lyman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • What Biosimilars Mean for Your Hematology/Oncology Practice 
    60th American Society of Hematology Annual Meeting - 11/30/2018
  • Paving the Way Forward: The Role of Post-Market Evidence Development, Education, and Guidance 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Oncology’s Side Effect Disconnect: The Messy Reality
    Oncology’s Side Effect Disconnect: The Messy RealityAugust 5th, 2025
  • Gary Herbert Lyman
    Gary Herbert LymanApril 21st, 2024
  • Risk of Chemotherapy-Induced Febrile Neutropenia in Intermediate-Risk Regimens: Clinical and Economic Outcomes of Granulocyte Colony-Stimulating Factor Prophylaxis
    Risk of Chemotherapy-Induced Febrile Neutropenia in Intermediate-Risk Regimens: Clinical and Economic Outcomes of Granulocyte Colony-Stimulating Factor ProphylaxisFebruary 1st, 2023

Professional Memberships

External Links

  • Wikipediahttps://en.wikipedia.org/wiki/Gary_Herbert_Lyman

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Gary Lyman, Dr. Gary Lyman, MD, Dr. G Lyman, Dr. Gary Herbert Lyman